397 related articles for article (PubMed ID: 23337036)
1. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
[TBL] [Abstract][Full Text] [Related]
2. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells.
Jullien N; Maudinet A; Leloutre B; Ringe J; Häupl T; Marie PJ
J Cell Biochem; 2012 Jun; 113(6):2047-56. PubMed ID: 22274864
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling.
Chen X; Hu W; Xie B; Gao H; Xu C; Chen J
Biochem Biophys Res Commun; 2014 May; 448(2):206-11. PubMed ID: 24785374
[TBL] [Abstract][Full Text] [Related]
5. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.
Riganti C; Salaroglio IC; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Bosia A; Ghigo D; Schiffer D
Neuro Oncol; 2013 Nov; 15(11):1502-17. PubMed ID: 23897632
[TBL] [Abstract][Full Text] [Related]
7. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
[TBL] [Abstract][Full Text] [Related]
8. Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors.
Ng FS; Toh TB; Ting EH; Koh GR; Sandanaraj E; Phong M; Wong SS; Leong SH; Kon OL; Tucker-Kellogg G; Ng WH; Ng I; Tang C; Ang BT
Clin Cancer Res; 2012 Aug; 18(15):4122-35. PubMed ID: 22675171
[TBL] [Abstract][Full Text] [Related]
9. Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.
Pulvirenti T; Van Der Heijden M; Droms LA; Huse JT; Tabar V; Hall A
Cancer Res; 2011 Dec; 71(23):7280-90. PubMed ID: 21990322
[TBL] [Abstract][Full Text] [Related]
10. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.
Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y
Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036
[TBL] [Abstract][Full Text] [Related]
11. WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma.
Denysenko T; Annovazzi L; Cassoni P; Melcarne A; Mellai M; Schiffer D
Cancer Genomics Proteomics; 2016; 13(1):31-45. PubMed ID: 26708597
[TBL] [Abstract][Full Text] [Related]
12. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.
Jin X; Jeon HY; Joo KM; Kim JK; Jin J; Kim SH; Kang BG; Beck S; Lee SJ; Kim JK; Park AK; Park WY; Choi YJ; Nam DH; Kim H
Cancer Res; 2011 Apr; 71(8):3066-75. PubMed ID: 21363911
[TBL] [Abstract][Full Text] [Related]
13. Wnt3a Promotes the Vasculogenic Mimicry Formation of Colon Cancer via Wnt/β-Catenin Signaling.
Qi L; Song W; Liu Z; Zhao X; Cao W; Sun B
Int J Mol Sci; 2015 Aug; 16(8):18564-79. PubMed ID: 26266404
[TBL] [Abstract][Full Text] [Related]
14. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
Cai C; Zhu X
Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
[TBL] [Abstract][Full Text] [Related]
15. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
[TBL] [Abstract][Full Text] [Related]
16. M2-like tumor-associated macrophages-secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating β-catenin pathway in thyroid cancer.
Lv J; Feng ZP; Chen FK; Liu C; Jia L; Liu PJ; Yang CZ; Hou F; Deng ZY
Mol Carcinog; 2021 Jan; 60(1):25-37. PubMed ID: 33283877
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
18. miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.
Zhang W; Shen C; Li C; Yang G; Liu H; Chen X; Zhu D; Zou H; Zhen Y; Zhang D; Zhao S
Mol Carcinog; 2016 May; 55(5):575-85. PubMed ID: 25764520
[TBL] [Abstract][Full Text] [Related]
19. GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling.
Matias D; Dubois LG; Pontes B; Rosário L; Ferrer VP; Balça-Silva J; Fonseca ACC; Macharia LW; Romão L; E Spohr TCLS; Chimelli L; Filho PN; Lopes MC; Abreu JG; Lima FRS; Moura-Neto V
Mol Neurobiol; 2019 Feb; 56(2):1517-1530. PubMed ID: 29948952
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
Pu P; Zhang Z; Kang C; Jiang R; Jia Z; Wang G; Jiang H
Cancer Gene Ther; 2009 Apr; 16(4):351-61. PubMed ID: 18949017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]